US Q4 Consumer Health Earnings Preview: Will Demand Or Shortage Have More Impact?

Demand for OTC pain relievers and cough/cold products jumped prior to October-December and remained high during quarter due to consumer concern not only about flu but also RSV and additional COVID-19 mutation. US and Canadian firms marketing OTC drugs and supplements also will be offering additional signals on planned spinoffs of consumer health businesses.

• Source: Shutterstock

High demand for OTC cough/cold and pain relief remedies in the US and Canada almost certainly point to consumer health firms reporting strong sales growth in the most recent quarter, with results for the Vicks line the first barometer as Procter & Gamble is first out of the sales-and-earnings gate.

US and Canadian firms marketing OTC drug and dietary supplement and reporting results for the October-December period also will be...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Asia

More from Geography